Loading company…
Minoryx Therapeutics SL is a Barcelona biotechnology company developing small-molecule drugs for CNS diseases such as X-ALD.
Founded in 2011 and based in Barcelona, Spain, Minoryx Therapeutics SL develops small-molecule drugs for CNS diseases, including X-linked adrenoleukodystrophy and Friedreich's ataxia. Its lead candidate is leriglitazone (MIN-102). In May 2022 it raised venture debt financing from unspecified investors, as part of a larger EUR 51 million series C and debt financing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in